Phase i study of alemtuzumab for therapy of steroid-refractory chronic graft-versus-host disease
Sarah Nikiforow, Haesook T. Kim, Bhavjot Bindra, Sean McDonough, Brett Glotzbecker, Philippe Armand, John Koreth, Vincent T. Ho, Edwin P. Alyea, Bruce R. Blazar, Jerome Ritz, Robert J. Soiffer, Joseph H. Antin, Corey S. Cutler
Dive into the research topics of 'Phase i study of alemtuzumab for therapy of steroid-refractory chronic graft-versus-host disease'. Together they form a unique fingerprint.